Article Sidebar
Date Published:
17/11/2025
Abstract Views: 75
Views pdf: 37
Views pdf: 37
Issue
Section
Các bài báo
How to Cite
Phạm, M. T., & Nguyễn, T. T. H. (2025). BETA-BLOCKER USAGE IN HF PATIENTS AFTER ACUTE DECOMPENSATED EPISODES: VNHI’S HF TREATMENT PRACTICE ACCORDING TO AHA-GWTG. Vietnam Medical Journal, 555(3). https://doi.org/10.51298/vmj.v555i3.16157
BETA-BLOCKER USAGE IN HF PATIENTS AFTER ACUTE DECOMPENSATED EPISODES: VNHI'S HF TREATMENT PRACTICE ACCORDING TO AHA-GWTG
Main Article Content
Abstract
Beta-blockers are one of the cornerstone therapies in the treatment of patients with heart failure with reduced ejection fraction (HFrEF). However, concerns about potential side effects or the congestive status of heart failure patients at discharge often lead to hesitancy in aggressively prescribing beta-blockers. This hinders the optimization of heart failure treatment, reducing their potential to improve cardiac function in these patients. In this study, we retrospectively evaluated changes in beta-blocker usage among HFrEF patients discharged after acute decompensation at the Vietnam National Heart Institute, Bach Mai Hospital, in 2023
Article Details
Keywords
heart failure, beta blockers, AHA-GWTG.
References
1. Rashid AM, Khan MS, Fudim M, DeWald TA, DeVore A, Butler J. Management of Heart Failure With Reduced Ejection Fraction. Curr Probl Cardiol. 2023 May;48(5):101596. doi: 10.1016 /j.cpcardiol.2023.101596. Epub 2023 Jan 18. PMID: 36681212.
2. Boen HM, Van Craenenbroeck EM. How to predict peak heart rate in heart failure patients on beta-blockers: a new answer to an old question. Eur J Prev Cardiol. 2022 Sep 7;29(12):1678-1679. doi: 10.1093/eurjpc/zwac130. PMID: 35853189.
3. Savarese G, Bodegard J, Norhammar A, Sartipy P, Thuresson M, Cowie MR, Fonarow GC, Vaduganathan M, Coats AJS. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden). Eur J Heart Fail. 2021 Sep;23(9):1499-1511. doi: 10.1002/ejhf.2271. Epub 2021 Jun 28. PMID: 34132001.
4. Fröhlich H, Torres L, Täger T, Schellberg D, Corletto A, Kazmi S, Goode K, Grundtvig M, Hole T, Katus HA, Cleland JGF, Atar D, Clark AL, Agewall S, Frankenstein L. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure. Clin Res Cardiol. 2017 Sep;106(9):711-721. doi: 10.1007/s00392-017-1115-0. Epub 2017 Apr 22. PMID: 28434020.
5. Paolillo S, Dell'Aversana S, Esposito I, Poccia A, Perrone Filardi P. The use of β-blockers in patients with heart failure and comorbidities: Doubts, certainties and unsolved issues. Eur J Intern Med. 2021 Jun;88:9-14. doi: 10.1016/j.ejim.2021.03.035. Epub 2021 Apr 30. PMID: 33941435.
6. Murphy SP, Ibrahim NE, Januzzi JL Jr. Heart Failure With Reduced Ejection Fraction: A Review. JAMA. 2020 Aug 4;324(5):488-504. doi: 10.1001/jama.2020.10262. Erratum in: JAMA. 2020 Nov 24;324(20): 2107. doi: 10.1001/jama. 2020.21736. PMID: 32749493.
7. Patel J, Rassekh N, Fonarow GC, Deedwania P, Sheikh FH, Ahmed A, Lam PH. Guideline-Directed Medical Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction. Drugs. 2023 Jun;83(9):747-759. doi: 10.1007/ s40265-023-01887-4. Epub 2023 May 31. PMID: 37254024.
8. Greene SJ, Butler J, Albert NM, DeVore AD, Sharma PP, Duffy CI, Hill CL, McCague K, Mi X, Patterson JH, Spertus JA, Thomas L, Williams FB, Hernandez AF, Fonarow GC. Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry. J Am Coll Cardiol. 2018 Jul 24;72(4):351-366. doi: 10.1016/j.jacc.2018.04.070. PMID: 30025570.
9. Gottlieb SS, Fisher ML, Kjekshus J, Deedwania P, Gullestad L, Vitovec J, Wikstrand J; MERIT-HF Investigators. Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Circulation. 2002 Mar 12;105(10): 1182-8. doi: 10.1161/hc1002.105180. PMID: 11889011.
10. Chopra HK. Bisoprolol and heart failure: new frontiers. Indian Heart J. 2010 Jan-Feb;62(1):7-12. PMID: 21180027.
2. Boen HM, Van Craenenbroeck EM. How to predict peak heart rate in heart failure patients on beta-blockers: a new answer to an old question. Eur J Prev Cardiol. 2022 Sep 7;29(12):1678-1679. doi: 10.1093/eurjpc/zwac130. PMID: 35853189.
3. Savarese G, Bodegard J, Norhammar A, Sartipy P, Thuresson M, Cowie MR, Fonarow GC, Vaduganathan M, Coats AJS. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden). Eur J Heart Fail. 2021 Sep;23(9):1499-1511. doi: 10.1002/ejhf.2271. Epub 2021 Jun 28. PMID: 34132001.
4. Fröhlich H, Torres L, Täger T, Schellberg D, Corletto A, Kazmi S, Goode K, Grundtvig M, Hole T, Katus HA, Cleland JGF, Atar D, Clark AL, Agewall S, Frankenstein L. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure. Clin Res Cardiol. 2017 Sep;106(9):711-721. doi: 10.1007/s00392-017-1115-0. Epub 2017 Apr 22. PMID: 28434020.
5. Paolillo S, Dell'Aversana S, Esposito I, Poccia A, Perrone Filardi P. The use of β-blockers in patients with heart failure and comorbidities: Doubts, certainties and unsolved issues. Eur J Intern Med. 2021 Jun;88:9-14. doi: 10.1016/j.ejim.2021.03.035. Epub 2021 Apr 30. PMID: 33941435.
6. Murphy SP, Ibrahim NE, Januzzi JL Jr. Heart Failure With Reduced Ejection Fraction: A Review. JAMA. 2020 Aug 4;324(5):488-504. doi: 10.1001/jama.2020.10262. Erratum in: JAMA. 2020 Nov 24;324(20): 2107. doi: 10.1001/jama. 2020.21736. PMID: 32749493.
7. Patel J, Rassekh N, Fonarow GC, Deedwania P, Sheikh FH, Ahmed A, Lam PH. Guideline-Directed Medical Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction. Drugs. 2023 Jun;83(9):747-759. doi: 10.1007/ s40265-023-01887-4. Epub 2023 May 31. PMID: 37254024.
8. Greene SJ, Butler J, Albert NM, DeVore AD, Sharma PP, Duffy CI, Hill CL, McCague K, Mi X, Patterson JH, Spertus JA, Thomas L, Williams FB, Hernandez AF, Fonarow GC. Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry. J Am Coll Cardiol. 2018 Jul 24;72(4):351-366. doi: 10.1016/j.jacc.2018.04.070. PMID: 30025570.
9. Gottlieb SS, Fisher ML, Kjekshus J, Deedwania P, Gullestad L, Vitovec J, Wikstrand J; MERIT-HF Investigators. Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Circulation. 2002 Mar 12;105(10): 1182-8. doi: 10.1161/hc1002.105180. PMID: 11889011.
10. Chopra HK. Bisoprolol and heart failure: new frontiers. Indian Heart J. 2010 Jan-Feb;62(1):7-12. PMID: 21180027.